AAEM case report #13: diabetic amyotrophy.
نویسندگان
چکیده
A case fulfilling the criteria for the diagnosis of diabetic amyotrophy is reported. Based on the clinical and electrodiagnostic features, it is concluded that diabetic amyotrophy is a recognizable clinical entity that can be differentiated from other diabetic neuropathies. The site of the lesion and the pathogenesis in diabetic amyotrophy remain controversial. The course of the illness is variable with gradual, but often incomplete, improvement.
منابع مشابه
CASE REPORT An unusual presentation of diabetic amyotrophy: myoclonus
To cite: Zaidi SA, Chhetri SK, Lekwuwa G, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2012008245 SUMMARY Diabetic amyotrophy is a distinctive form of diabetic neuropathy. It is characterised by a weakness and wasting of proximal muscles of the lower limbs with associated pain. We report a case of an elderly patient with unusual presentation of diabetic ...
متن کاملConcomitance of diabetic neuropathic amyotrophy and cachexia: a case report with review of the literature
Diabetic amyotrophy is a rare condition in which patients develop severe aching or burning pain in hips and thighs. This is followed by weakness and wasting of the muscles of proximal lower extremities, which often occur asymmetrically. Diabetic neuropathic cachexia is a different type of diabetic neuropathies. It leads to intense pain in affected extremities accompained by anorexia, weight los...
متن کاملCASE REPORTS Human immunoglobulin for diabetic amyotrophy—a promising prospect?
Diabetic neuropathies are universally recognised and cause significant morbidity. At present improving glycaemic control is the only recognised treatment. A man with type 2 diabetes presented with disabling asymmetric lower limb proximal neuropathy. Rapid clinical, functional, and electrical improvement followed treatment with intravenous immunoglobulin. The aetiology of diabetic amyotrophy rem...
متن کاملHuman immunoglobulin for diabetic amyotrophy--a promising prospect?
Diabetic neuropathies are universally recognised and cause significant morbidity. At present improving glycaemic control is the only recognised treatment. A man with type 2 diabetes presented with disabling asymmetric lower limb proximal neuropathy. Rapid clinical, functional, and electrical improvement followed treatment with intravenous immunoglobulin. The aetiology of diabetic amyotrophy rem...
متن کاملIntravenous immunoglobulin therapy for diabetic amyotrophy.
A 49-year-old woman with diabetes mellitus developed progressive weakness and atrophy of both thighs rendering her wheelchair-bound within two months. The neurological findings and electrophysiological test results were compatible with diabetic amyotrophy (DA). Immediately after intravenous immunoglobulin (IVIg) therapy (20 g x 3 days), she became able to walk with a cane. After the next course...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Muscle & nerve
دوره 19 8 شماره
صفحات -
تاریخ انتشار 1987